What other conditions could weight-loss drugs treat?
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’s
Read more at Financial Times
-
Musk pitches weight-loss drugs to lower health care spending
Politico - 17h -
Some health experts warn against microdosing weight loss drugs
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some ...CBS News - 2d -
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.CNBC - 3d -
If DOGE Treats Government Like a Business, It Could Be a Disaster
A lot of what the government does is hard to quantify and involves complicated tasks that inevitably require bureaucratic coordination and, yes, inefficiency.The New York Times - 4d -
Weight-loss drug Mounjaro 'changed my life,' says mother-of-two
People struggling with their weight welcome the NHS rollout of Mounjaro but worry about delays.BBC News - 6d -
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.CNBC - 6d -
Millions will have to wait up to 12 years for NHS weight-loss drug
Fears that giving 3.4 million people immediate access to new weight-loss drug could overwhelm NHS.BBC News - 6d -
Will Trump nix Biden’s coverage plan for weight-loss drugs? It’ll be a close call.
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says it’s possible he could end up supporting the Democratic incumbent’s ...MarketWatch - Dec. 4 -
A rival weight loss drug to Wegovy helped people shed more pounds, study shows
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.NBC News - Dec. 4
More from Financial Times
-
Nato’s European members discuss 3% target for defence spending
Financial Times - 2h -
Keir Starmer to hold talks with the EU on defence co-operation
Financial Times - 7h -
James Dyson is right to fight for British strawberries
Financial Times - 2h -
Murdoch family feud left hanging over media empire’s future
Financial Times - 2h -
Asian stocks rise after US inflation data clears way for rate cut
Financial Times - 1h